Research Paper Volume 13, Issue 2 pp 2101—2117

miR-588 is a prognostic marker in gastric cancer

Expression of CXCL5, CXCL9, and CXCL10 in immune cells. (A) CXCL5 shows significantly high expression in monocytes, CD4+ T cells, and CD8+ T cells. (B, C) CXCL9 and CXCL10 show significantly high expression in CD4+ T cells and CD8+ T cells.

Figure 3. Expression of CXCL5, CXCL9, and CXCL10 in immune cells. (A) CXCL5 shows significantly high expression in monocytes, CD4+ T cells, and CD8+ T cells. (B, C) CXCL9 and CXCL10 show significantly high expression in CD4+ T cells and CD8+ T cells.